Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine

References

• Hamed SA. The vascular risk associations with migraine: relation to migraine susceptibility and progression. Atherosclerosis. 2009 Jul;205(1):15–22.
   PubMed Web of Science ®Google Scholar
• Martins LB, Duarte H, Ferreira AV, et al. Migraine is associated with altered levels of neurotrophins. Neurosci Lett. 2015;587:6–10.
   PubMed Web of Science ®Google Scholar
• Ward TN. Migraine diagnosis and pathophysiology. Continuum (Minneap Minn). 2012;18(4):753–763.
   PubMedGoogle Scholar
• Scheff SW, Price DA, Ansari MA, et al. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer’s disease. J Alzheimers Dis. 2015;43(3):1073–1090. DOI:10.3233/JAD-141518
   PubMed Web of Science ®Google Scholar
• Braunewell K, Riederer P, Spilker C, et al. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cognit Disord. 2001 Mar-Apr;12(2):110–116.
   PubMed Web of Science ®Google Scholar
• Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43(2):221–225.
   PubMed Web of Science ®Google Scholar
• Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol. 2009;5(7):1065–1082.
   PubMed Web of Science ®Google Scholar
• Nishikawa KC, Millis AJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003;287(1):79–87.
   PubMed Web of Science ®Google Scholar
• Prakash M, Bodas M, Prakash D, et al. Diverse pathological implications of YKL-40: answers may lie in ‘outside-in’ signaling. Cell Signal. 2013 Jul;25(7):1567–1573.
   PubMed Web of Science ®Google Scholar
• Rosen C, Andersson CH, Andreasson U, et al. Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2014;4:297–304.
   PubMedGoogle Scholar
• Dönder A, Özdemir HH. Serum YKL-40 levels in patients with multiple sclerosis. Arq Neuropsiquiatr. 2021 Sep;79(9):795–798.
   PubMed Web of Science ®Google Scholar
• McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 2006 Jan;27(1):17–23.
   PubMed Web of Science ®Google Scholar
• Tang C, Chen S, Qian H, et al. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012 Feb;135(2):112–124.
   PubMed Web of Science ®Google Scholar
• Choi KM, Lee JS, Kim EJ, et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008 Feb;158(2):203–207.
   PubMed Web of Science ®Google Scholar
• Dekens DW, Naudé PJ, Engelborghs S, et al. Neutrophil gelatinase-associated lipocalin and its receptors in Alzheimer’s Disease (AD) brain regions: differential Findings in AD with and without depression. J Alzheimers Dis. 2017;55(2):763–776. DOI:10.3233/JAD-160330
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi:10.1177/0333102413485658 doi: doi: doi: . doi: ed.
   Google Scholar
• Braunewell KH, Klein-Szanto AJ. Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins. Cell Tissue Res. 2009 Feb;335(2):301–316.
   PubMed Web of Science ®Google Scholar
• Ames JB, Ishima R, Tanaka T, et al. Molecular mechanics of calcium-myristoyl switches. Nature. 1997 Sep 11;389(6647):198–202.
   PubMed Web of Science ®Google Scholar
• Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med. 2009 Mar;15(3):89–100.
   PubMed Web of Science ®Google Scholar
• Tarawneh R, Ford AL, Ohlendorf M, et al. Visinin-like protein-1 (VILIP- 1): a novel plasma biomarker for the detection of acute cortical ischemic stroke. Stroke. 2011;42:E203–1203.
   Web of Science ®Google Scholar
• Gargus JJ. Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine and autism. Ann N Y Acad Sci. 2009 Jan;1151:133–156.
   PubMed Web of Science ®Google Scholar
• Blandini F, Braunewell KH, Manahan-Vaughan D, et al. Neurodegeneration and energy metabolism: from chemistry to clinics. Cell Death Differ. 2004 Apr;11(4):479–484.
   PubMed Web of Science ®Google Scholar
• Bonneh-Barkay D, Bissel SJ, Wang G, et al. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol. 2008 Jul;173(1):130–143.
   PubMed Web of Science ®Google Scholar
• Erzin Y, Uzun H, Karatas A, et al. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn’s disease. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e357–62.
   PubMed Web of Science ®Google Scholar
• Villar-Piqué A, Schmitz M, Hermann P, et al. Plasma YKL-40 in the spectrum of neurodegenerative dementia. J Neuroinflammation. 2019 Jul 12;16(1):145.
   PubMedGoogle Scholar
• Long X, Hu H, Li S, et al. Hippocampal YKL-40 expression in rats after status epilepticus. Epilepsy Res. 2016 Sep;125:52–57.
   PubMed Web of Science ®Google Scholar
• Kang SS, Ren Y, Liu CC, et al. Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry. 2018 Feb;23(2):344–350.
   PubMed Web of Science ®Google Scholar
• Dekens DW, Naudé PJW, Keijser JN, et al. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model. J Neuroinflammation. 2018 Nov 30;15(1):330.
   PubMedGoogle Scholar
• Nam Y, Kim JH, Seo M, et al. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. J Biol Chem. 2014 Jun 13;289(24):16773–89.
   PubMed Web of Science ®Google Scholar
• Lee S, Jha MK, Suk K. Lipocalin-2 in the inflammatory activation of brain astrocytes. CritRevImmunol. 2015;35(1):77–84.
   Web of Science ®Google Scholar
• Goadsby PJ, Knight YE, Hoskin KL, et al. Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow. Brain Res. 1997 Mar 21;751(2):247–252.
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000 Nov;13(5):715–725.
   PubMed Web of Science ®Google Scholar
• Gelderblom M, Arunachalam P, Magnus T. γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration. Front Cell Neurosci. 2014 Nov 5;8:368. DOI:10.3389/fncel.2014.00368.
   PubMed Web of Science ®Google Scholar
• Krakauer M, Sorensen P, Khademi M, et al. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler. 2008 Jun;14(5):622–630.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhong D, Zheng Y, et al. Damage effect of interleukin (IL)-23 on oxygen-glucose-deprived cells of the neurovascular unit via IL-23 receptor. Neuroscience. 2015 Mar 19;289:406–416.
   PubMed Web of Science ®Google Scholar
• Backes FN, de Souza A, Bianchin MM. IL-23 and IL-17 in acute ischemic stroke: correlation with stroke scales and prognostic value. Clin Biochem. 2021 Dec;98:29–34.
   PubMed Web of Science ®Google Scholar
• Mohammadi Shahrokhi V, Ravari A, Mirzaei T, et al. IL-17A and IL-23: plausible risk factors to induce age-associated inflammation in Alzheimer’s disease. Immunol Invest. 2018 Nov;47(8):812–822.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003 Feb 13;421(6924):744–748.
   PubMed Web of Science ®Google Scholar
• Fidan I, Yüksel S, Ymir T, et al. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006 Feb;171(1–2):184–188.
   PubMed Web of Science ®Google Scholar
• Yücel M, Kotan D, Gurol Çiftçi G, et al. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):930–936.
   PubMed Web of Science ®Google Scholar